Biologic therapy for rheumatoid arthritis in developing countries--a place for non-TNF inhibitors as first-line treatment?

Rheumatology (Oxford). 2015 Feb;54(2):208-9. doi: 10.1093/rheumatology/keu040. Epub 2014 Mar 31.

¹ Division of Rheumatology, Chris Hani Baragwanath Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg and Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. mohammed.tikly@wits.ac.za.
² Division of Rheumatology, Chris Hani Baragwanath Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg and Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Division of Rheumatology, Chris Hani Baragwanath Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg and Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
³ Division of Rheumatology, Chris Hani Baragwanath Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg and Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

No abstract available

Publication types